Peripheral insulin resistance is associated with decreasing adiponectin and increasing leptin plasma levels, and also with cognitive decline. The effects of adipokines on brain function have been published from both animal and human studies. In particular, the influence of leptin and adiponectin on the development of Alzheimer's disease (AD) has been extensively investigated. However, the association between adipsin and AD is as yet unknown. In 37 patients with AD and 65 controls that followed the same study protocol, we tested whether adiponectin, leptin, and adipsin could be used as biomarkers in the early stages of AD. In contrast with conclusions of cognition studies in insulin resistant states, our study found a correlation of impaired neuropsychological performance with increasing adiponectin and decreasing leptin in AD patients. Nevertheless, no significant differences between patients and controls were found. AD women had significantly increased adipsin compared to controls, and there was a positive correlation of adipsin with age and disease duration. Although adipokines do not appear to be suitable biomarkers for early AD diagnosis, they certainly play a role in the pathogenesis of AD. Further studies will be needed to explain the cause of the adipokine "breaking point" that leads to the pathogenesis of overt AD.

Department of Molecular Endocrinology Institute of Endocrinology Prague Czech Republic

Zobrazit více v PubMed

ARNOLD SE, ARVANITAKIS Z, MACAULEY-RAMBACH SL, KOENIG AM, WANG HY, AHIMA RS, CRAFT S, GANDY S, BUETTNER C, STOECKEL LE, HOLTZMAN DM, NATHAN DM. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol. 2018;14:168–181. doi: 10.1038/nrneurol.2017.185. PubMed DOI PMC

ARNOLDUSSEN IA, KILIAAN AJ, GUSTAFSON DR. Obesity and dementia: adipokines interact with the brain. Eur Neuropsychopharmacol. 2014;24:1982–1999. doi: 10.1016/j.euroneuro.2014.03.002. PubMed DOI PMC

BARANOWSKA-BIK A, KALISZ M, MARTYNSKA L, WOLINSKA-WITORT E, STYCZYNSKA M, CHODAKOWSKA-ZEBROWSKA M, BARCIKOWSKA M, BARANOWSKA B, BIK W. Plasma adiponectin array in women with Alzheimer’s disease. Endokrynol Pol. 2018;69:550–559. doi: 10.5603/EP.a2018.0055. PubMed DOI

BARRETT-CONNOR E, EDELSTEIN SL, COREY-BLOOM J, WIEDERHOLT WC. Weight loss precedes dementia in community-dwelling older adults. J Am Geriatr Soc. 1996;44:1147–1152. doi: 10.1111/j.1532-5415.1996.tb01362.x. PubMed DOI

CAI H, CONG WN, JI S, ROTHMAN S, MAUDSLEY S, MARTIN B. Metabolic dysfunction in Alzheimer’s disease and related neurodegenerative disorders. Curr Alzheimer Res. 2012;9:5–17. doi: 10.2174/156720512799015064. PubMed DOI PMC

CEDIKOVA M, PITULE P, KRIPNEROVA M, MARKOVA M, KUNCOVA J. Multiple roles of mitochondria in aging processes. Physiol Res. 2016;65(Suppl 5):S519–S531. doi: 10.33549/physiolres.933538. PubMed DOI

CHEDRAUI P, PEREZ-LOPEZ FR, ESCOBAR GS, PALLA G, MONTT-GUEVARA M, CECCHI E, GENAZZANI AR, SIMONCINI T RESEARCH GROUP FOR THE OMEGA WOMEN’S HEALTH P. Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome. Maturitas. 2014;79:86–90. doi: 10.1016/j.maturitas.2014.06.008. PubMed DOI

CHEN R, SHU Y, ZENG Y. Links between adiponectin and dementia: from risk factors to pathophysiology. Front Aging Neurosci. 2019;11:356. doi: 10.3389/fnagi.2019.00356. PubMed DOI PMC

De FRANCISCIS P, BARBIERI M, LEO S, DALISE AM, SARDU C, MARFELLA R, COLACURCI N, PAOLISSO G, RIZZO MR. Serum adiponectin levels are associated with worse cognitive function in postmenopausal women. PLoS One. 2017;12:e0186205. doi: 10.1371/journal.pone.0186205. PubMed DOI PMC

De la MONTE SM, TONG M, DAIELLO LA, OTT BR. Early-stage Alzheimer’s disease is associated with simultaneous systemic and central nervous system dysregulation of insulin-linked metabolic pathways. J Alzheimers Dis. 2019;68:657–668. doi: 10.3233/JAD-180906. PubMed DOI PMC

FERRARIO CR, REAGAN LP. Insulin-mediated synaptic plasticity in the CNS: anatomical, functional and temporal contexts. Neuropharmacology. 2018;136:182–191. doi: 10.1016/j.neuropharm.2017.12.001. PubMed DOI PMC

FOLCH J, PEDROS I, PATRACA I, SUREDA F, JUNYENT F, BEAS-ZARATE C, VERDAGUER E, PALLAS M, AULADELL C, CAMINS A. Neuroprotective and anti-ageing role of leptin. J Mol Endocrinol. 2012;49:R149–R156. doi: 10.1530/JME-12-0151. PubMed DOI

FORNY-GERMANO L, De FELICE FG, VIEIRA M. The role of leptin and adiponectin in obesity-associated cognitive decline and Alzheimer’s disease. Front Neurosci. 2018;12:1027. doi: 10.3389/fnins.2018.01027. PubMed DOI PMC

FREEDMAN DS, THORNTON JC, PI-SUNYER FX, HEYMSFIELD SB, WANG J, PIERSON RN, JR, BLANCK HM, GALLAGHER D. The body adiposity index (hip circumference/height(1.5)) is not a more accurate measure of adiposity than is BMI, waist circumference, or hip circumference. Obesity (Silver Spring) 2012;20:2438–2444. doi: 10.1038/oby.2012.81. PubMed DOI PMC

GILBERT T, ROCHE S, BLOND E, BAR JY, DRAI J, CUERQ C, HAUTION-BITKER M, ECOCHARD R, BONNEFOY M. Association between peripheral leptin and adiponectin levels and cognitive decline in patients with neurocognitive disorders >/=65 years. J Alzheimers Dis. 2018;66:1255–1264. doi: 10.3233/JAD-180533. PubMed DOI PMC

GILLETTE GUYONNET S, ABELLAN Van KAN G, ALIX E, ANDRIEU S, BELMIN J, BERRUT G, BONNEFOY M, BROCKER P, CONSTANS T, FERRY M, GHISOLFI-MARQUE A, GIRARD L, GONTHIER R, GUERIN O, HERVY MP, JOUANNY P, LAURAIN MC, LECHOWSKI L, NOURHASHEMI F, RAYNAUD-SIMON A, RITZ P, ROCHE J, ROLLAND Y, SALVA T, VELLAS B. IANA (International Academy on Nutrition and Aging) Expert Group: weight loss and Alzheimer’s disease. J Nutr Health Aging. 2007;11:38–48. PubMed

GRECO SJ, HAMZELOU A, JOHNSTON JM, SMITH MA, ASHFORD JW, TEZAPSIDIS N. Leptin boosts cellular metabolism by activating AMPK and the sirtuins to reduce tau phosphorylation and beta-amyloid in neurons. Biochem Biophys Res Commun. 2011;414:170–174. doi: 10.1016/j.bbrc.2011.09.050. PubMed DOI PMC

GUO D, YUAN Y, HUANG R, TIAN S, WANG J, LIN H, AN K, HAN J, WANG S. Association between plasma adipsin level and mild cognitive impairment in Chinese patients with type 2 diabetes: a cross-sectional study. BMC Endocr Disord. 2019;19:108. doi: 10.1186/s12902-019-0431-y. PubMed DOI PMC

GURSOY CALAN O, CALAN M, YESIL SENSES P, UNAL KOCABAS G, OZDEN E, SARI KR, KOCAR M, IMAMOGLU C, SENSES YM, BOZKAYA G, BILGIR O. Increased adipsin is associated with carotid intima media thickness and metabolic disturbances in polycystic ovary syndrome. Clin Endocrinol (Oxf) 2016;85:910–917. doi: 10.1111/cen.13157. PubMed DOI

HO JE, LYASS A, COURCHESNE P, CHEN G, LIU C, YIN X, HWANG SJ, MASSARO JM, LARSON MG, LEVY D. Protein biomarkers of cardiovascular disease and mortality in the community. J Am Heart Assoc. 2018;7:e008108. doi: 10.1161/JAHA.117.008108. PubMed DOI PMC

HOLSCHER C. Insulin signaling impairment in the brain as a risk factor in Alzheimer’s disease. Front Aging Neurosci. 2019;11:88. doi: 10.3389/fnagi.2019.00088. PubMed DOI PMC

KADOWAKI T, YAMAUCHI T, KUBOTA N, HARA K, UEKI K, TOBE K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006;116:1784–1792. doi: 10.1172/JCI29126. PubMed DOI PMC

KANG S, LEE YH, LEE JE. Metabolism-centric overview of the pathogenesis of Alzheimer’s disease. Yonsei Med J. 2017;58:479–488. doi: 10.3349/ymj.2017.58.3.479. PubMed DOI PMC

KHEMKA VK, BAGCHI D, BANDYOPADHYAY K, BIR A, CHATTOPADHYAY M, BISWAS A, BASU D, CHAKRABARTI S. Altered serum levels of adipokines and insulin in probable Alzheimer’s disease. J Alzheimers Dis. 2014;41:525–533. doi: 10.3233/JAD-140006. PubMed DOI

KIRKLAND JL. Translating advances from the basic biology of aging into clinical application. Exp Gerontol. 2013;48:1–5. doi: 10.1016/j.exger.2012.11.014. PubMed DOI PMC

KUEHN BM. In Alzheimer research, glucose metabolism moves to center stage. JAMA. 2020 doi: 10.1001/jama.2019.20939. PubMed DOI

LI S, SHIN HJ, DING EL, Van DAM RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2009;302:179–188. doi: 10.1001/jama.2009.976. PubMed DOI

LO JC, LJUBICIC S, LEIBIGER B, KERN M, LEIBIGER IB, MOEDE T, KELLY ME, CHATTERJEE BHOWMICK D, MURANO I, COHEN P, BANKS AS, KHANDEKAR MJ, DIETRICH A, FLIER JS, CINTI S, BLUHER M, DANIAL NN, BERGGREN PO, SPIEGELMAN BM. Adipsin is an adipokine that improves beta cell function in diabetes. Cell. 2014;158:41–53. doi: 10.1016/j.cell.2014.06.005. PubMed DOI PMC

MA J, ZHANG W, WANG HF, WANG ZX, JIANG T, TAN MS, YU JT, TAN L. Peripheral blood adipokines and insulin levels in patients with Alzheimer’s disease: a replication study and meta-analysis. Curr Alzheimer Res. 2016;13:223–233. doi: 10.2174/156720501303160217111434. PubMed DOI

MAGALHAES CA, CARVALHO MG, SOUSA LP, CARAMELLI P, GOMES KB. Leptin in Alzheimer’s disease. Clin Chim Acta. 2015;450:162–168. doi: 10.1016/j.cca.2015.08.009. PubMed DOI

MATTHEWS DR, HOSKER JP, RUDENSKI AS, NAYLOR BA, TREACHER DF, TURNER RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419. doi: 10.1007/BF00280883. PubMed DOI

McGREGOR G, HARVEY J. Food for thought: leptin regulation of hippocampal function and its role in Alzheimer’s disease. Neuropharmacology. 2018;136:298–306. doi: 10.1016/j.neuropharm.2017.09.038. PubMed DOI

NCEP ATP III – Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–3421. doi: 10.1161/circ.106.25.3143. PubMed DOI

NOVOTNY D, VAVERKOVA H, KARASEK D, LUKES J, SLAVIK L, MALINA P, ORSAG J. Evaluation of total adiponectin, adipocyte fatty acid binding protein and fibroblast growth factor 21 levels in individuals with metabolic syndrome. Physiol Res. 2014;63:219–228. doi: 10.33549/physiolres.932602. PubMed DOI

OANIA R, McEVOY LK. Plasma leptin levels are not predictive of dementia in patients with mild cognitive impairment. Age Ageing. 2015;44:53–58. doi: 10.1093/ageing/afu160. PubMed DOI PMC

OOMURA Y, HORI N, SHIRAISHI T, FUKUNAGA K, TAKEDA H, TSUJI M, MATSUMIYA T, ISHIBASHI M, AOU S, LI XL, KOHNO D, URAMURA K, SOUGAWA H, YADA T, WAYNER MJ, SASAKI K. Leptin facilitates learning and memory performance and enhances hippocampal CA1 long-term potentiation and CaMK II phosphorylation in rats. Peptides. 2006;27:2738–2749. doi: 10.1016/j.peptides.2006.07.001. PubMed DOI

PALLA G, RAMIREZ-MORAN C, MONTT-GUEVARA MM, SALAZAR-POUSADA D, SHORTREDE J, SIMONCINI T, GRIJALVA-GRIJALVA I, PEREZ-LOPEZ FR, CHEDRAUI P. Perimenopause, body fat, metabolism and menopausal symptoms in relation to serum markers of adiposity, inflammation and digestive metabolism. J Endocrinol Invest. 2020;43:809–820. doi: 10.1007/s40618-019-01168-6. PubMed DOI

ROBERTS WC. The Friedewald-Levy-Fredrickson formula for calculating low-density lipoprotein cholesterol, the basis for lipid-lowering therapy. Am J Cardiol. 1988;62:345–346. doi: 10.1016/0002-9149(88)90248-2. PubMed DOI

SCHMID A, HOCHBERG A, BERGHOFF M, SCHLEGEL J, KARRASCH T, KAPS M, SCHAFFLER A. Quantification and regulation of adipsin in human cerebrospinal fluid (CSF) Clin Endocrinol (Oxf) 2016;84:194–202. doi: 10.1111/cen.12856. PubMed DOI

SERGI G, De RUI M, COIN A, INELMEN EM, MANZATO E. Weight loss and Alzheimer’s disease: temporal and aetiologic connections. Proc Nutr Soc. 2013;72:160–165. doi: 10.1017/S0029665112002753. PubMed DOI

STOUT MB, JUSTICE JN, NICKLAS BJ, KIRKLAND JL. Physiological aging: links among adipose tissue dysfunction, diabetes, and frailty. Physiology (Bethesda) 2017;32:9–19. doi: 10.1152/physiol.00012.2016. PubMed DOI PMC

TEUNISSEN CE, Van der FLIER WM, SCHELTENS P, DUITS A, WIJNSTOK N, NIJPELS G, DEKKER JM, BLANKENSTEIN RM, HEIJBOER AC. Serum leptin is not altered nor related to cognitive decline in Alzheimer’s disease. J Alzheimers Dis. 2015;44:809–813. doi: 10.3233/JAD-141503. PubMed DOI

Van HIMBERGEN TM, BEISER AS, AI M, SESHADRI S, OTOKOZAWA S, AU R, THONGTANG N, WOLF PA, SCHAEFER EJ. Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and Alzheimer disease: results from the Framingham Heart Study. Arch Neurol. 2012;69:594–600. doi: 10.1001/archneurol.2011.670. PubMed DOI PMC

VEJRAZKOVA D, LISCHKOVA O, VANKOVA M, STANICKA S, VRBIKOVA J, LUKASOVA P, VCELAK J, VACINOVA G, BENDLOVA B. Distinct response of fat and gastrointestinal tissue to glucose in gestational diabetes mellitus and polycystic ovary syndrome. Physiol Res. 2017;66:283–292. doi: 10.33549/physiolres.933366. PubMed DOI

WANG HY, CAPUANO AW, KHAN A, PEI Z, LEE KC, BENNETT DA, AHIMA RS, ARNOLD SE, ARVANITAKIS Z. Insulin and adipokine signaling and their cross-regulation in postmortem human brain. Neurobiol Aging. 2019;84:119–130. doi: 10.1016/j.neurobiolaging.2019.08.012. PubMed DOI PMC

WANG JS, LEE WJ, LEE IT, LIN SY, LEE WL, LIANG KW, SHEU WH. Association between serum adipsin levels and insulin resistance in subjects with various degrees of glucose intolerance. J Endocr Soc. 2019;3:403–410. doi: 10.1210/js.2018-00359. PubMed DOI PMC

WARAGAI M, HO G, TAKAMATSU Y, SEKIYAMA K, SUGAMA S, TAKENOUCHI T, MASLIAH E, HASHIMOTO M. Importance of adiponectin activity in the pathogenesis of Alzheimer’s disease. Ann Clin Transl Neurol. 2017;4:591–600. doi: 10.1002/acn3.436. PubMed DOI PMC

WARAGAI M, HO G, TAKAMATSU Y, WADA R, SUGAMA S, TAKENOUCHI T, MASLIAH E, HASHIMOTO M. Adiponectin paradox in Alzheimer’s disease; relevance to amyloidogenic evolvability? Front Endocrinol (Lausanne) 2020;11:108. doi: 10.3389/fendo.2020.00108. PubMed DOI PMC

WARREN MW, HYNAN LS, WEINER MF. Lipids and adipokines as risk factors for Alzheimer’s disease. J Alzheimers Dis. 2012;29:151–157. doi: 10.3233/JAD-2012-111385. PubMed DOI PMC

WU ZJ, CHENG YJ, GU WJ, AUNG LH. Adiponectin is associated with increased mortality in patients with already established cardiovascular disease: a systematic review and meta-analysis. Metabolism. 2014;63:1157–1166. doi: 10.1016/j.metabol.2014.05.001. PubMed DOI

YAMAUCHI T, KAMON J, ITO Y, TSUCHIDA A, YOKOMIZO T, KITA S, SUGIYAMA T, MIYAGISHI M, HARA K, TSUNODA M, MURAKAMI K, OHTEKI T, UCHIDA S, TAKEKAWA S, WAKI H, TSUNO NH, SHIBATA Y, TERAUCHI Y, FROGUEL P, TOBE K, KOYASU S, TAIRA K, KITAMURA T, SHIMIZU T, NAGAI R, KADOWAKI T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003;423:762–769. doi: 10.1038/nature01705. PubMed DOI